Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Complement Inhibitors (Intracellular/Complosome-Targeted)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-07-29 — Complosome as a key modulator of cellular senescence, aging and age-related diseases.: Review consolidates the complosome (intracellular C3/C5) as a cross-cutting modulator of cellular senescence, inflammaging, and multiple aging hallmarks via mTOR/NF-κB/AMPK crosstalk, and nominates intracellular-selective complement inhibitors, RNAi, PROTACs, and targeted nanodelivery as candidate aging interventions — mechanistic synthesis, no outcome study yet. [mechanism-plausible] (novelty: 3)

Open questions

Related

Contributing findings

pubmed review mechanism-plausible
Complosome as a key modulator of cellular senescence, aging and age-related diseases.
29-jul-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18